Anacor
Anacor, also known as Anacor Pharmaceuticals, was a biopharmaceutical company focused on the development of novel treatments for inflammatory and infectious diseases. The company was founded in 1995 and was headquartered in Palo Alto, California. Anacor's research and development efforts were primarily concentrated on topical medications.
The company's most notable product was Kerydin (tavaborole), a topical antifungal medication approved by the U.S.
Anacor's business model involved both internal research and development and strategic partnerships. The company aimed to